Article
Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2.
Clinical pharmacology and therapeutics - 1 Jun 2021
Bachmann Fabio, Duthaler Urs, Meyer Zu Schwabedissen Henriette E, Puchkov Maxim, Huwyler Jörg, Haschke Manuel, Krähenbühl Stephan
Abstract excerpt
Metamizole is an analgesic and antipyretic drug used intensively in certain countries. Previous studies have shown that metamizole induces cytochrome (CYP) 2B6 and possibly CYP3A4. So far, it is unknown whether metamizole induces additional CYPs and by which mechanism. Therefore, we assessed the activity of 6 different CYPs in 12 healthy male subjects before and after treatment with 3 g of metamizole per day for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
